Press Release

Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting

Executive to Present Session: “Evaluate the Importance of Financial Transparency to Maximize Stakeholder Collaboration”

King of Prussia, PA – December 6, 2016 – Greenphire, the global leader in clinical payment solutions, announced today that it is sponsoring The Second Annual Clinical Trial Agreements, Investigator Payments and FMV meeting, taking place on December 6-7th, 2016 in Philadelphia. The event, focused on building solutions for financial management between research sites and trial sponsors, is being hosted by the Society for Clinical Research Sites (SCRS) in association with CBI.

In addition to sponsoring the meeting, Greenphire’s Vice President of Product Management, Kyle Cunningham, will host a session titled “Evaluate the Importance of Financial Transparency to Maximize Stakeholder Collaboration” on December 6th at 2:30pm for attendees. The session will deliver strategies to create clean and comprehensive transparent data that can back up clinical findings, increase operational efficiencies and reduce risks.

The meeting will take place from December 6th – 7th at the Doubletree Hilton in Philadelphia, PA.

For more information and the full schedule of speakers, visit: http://www.cbinet.com/conference/pc16306

About Greenphire
Greenphire is the leader in global clinical trial payment solutions. Greenphire’s best-in-class solutions optimize clinical trial performance by simplifying and streamlining payment processes from sponsors and CROs to sites and patients. Greenphire’s ClinCard and eClinicalGPS solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Share

Share on LinkedInEmail to someoneTweet about this on TwitterShare on FacebookGoogle+